OpenAlex
PricingAboutJobs
Log inGet started
Work

Results of docetaxel plus oxaliplatin (DOCOX)±cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study

HTML

Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Journal of Cancer
DOI: 10.1016/j.ejca.2013.04.022
Authors: Donald Richards, Darren M. Kocs, Alexander I. Spira, A. David McCollum, Sami Diab, Lanny I. Hecker, Allen Cohn, Feng Zhan, Lina Asmar
Institutions: McKesson (United States), Texas Oncology, Virginia Cancer Specialists, Rocky Mountain Cancer Centers, Arizona Oncology
Language: English

Topic: Gastric Cancer Management and Outcomes
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: docetaxel, oxaliplatin, metastatic gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, combination chemotherapy, progression-free survival, KRAS status, EGFR inhibition, neutropenia, adverse events, response rate, overall survival, duration of response, first-line therapy, second-line therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2014908282
FWCI: 3.97
Cites: 37
Cited by: 48
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security